Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting
Clinical trial NCT01175707 · TERMINATED
Trial details
- NCT number
- NCT01175707
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-15
- Primary completion
- 2011-11-17
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.